ZA201001246B - A process for isolation and purification of a target protein free of prion protein (PRPSC) - Google Patents
A process for isolation and purification of a target protein free of prion protein (PRPSC)Info
- Publication number
- ZA201001246B ZA201001246B ZA201001246A ZA201001246A ZA201001246B ZA 201001246 B ZA201001246 B ZA 201001246B ZA 201001246 A ZA201001246 A ZA 201001246A ZA 201001246 A ZA201001246 A ZA 201001246A ZA 201001246 B ZA201001246 B ZA 201001246B
- Authority
- ZA
- South Africa
- Prior art keywords
- prpsc
- isolation
- purification
- protein
- free
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
- B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
- B01D15/3828—Ligand exchange chromatography, e.g. complexation, chelation or metal interaction chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
- B01D15/424—Elution mode
- B01D15/426—Specific type of solvent
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/12—Purification
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/34—Size selective separation, e.g. size exclusion chromatography, gel filtration, permeation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/361—Ion-exchange
- B01D15/362—Cation-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3847—Multimodal interactions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
- B01J39/26—Cation exchangers for chromatographic processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J41/00—Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
- B01J41/20—Anion exchangers for chromatographic processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/165—Extraction; Separation; Purification by chromatography mixed-mode chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07114856A EP2027875A1 (de) | 2007-08-23 | 2007-08-23 | Verfahren zur Isolierung und Reinigung eines prionenproteinfreien Target-Proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA201001246B true ZA201001246B (en) | 2010-10-27 |
Family
ID=38720286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA201001246A ZA201001246B (en) | 2007-08-23 | 2010-02-22 | A process for isolation and purification of a target protein free of prion protein (PRPSC) |
Country Status (16)
Country | Link |
---|---|
US (2) | US9296799B2 (de) |
EP (3) | EP2027875A1 (de) |
JP (1) | JP5797404B2 (de) |
KR (1) | KR20100057614A (de) |
CN (1) | CN101842121B (de) |
AU (1) | AU2008290482B2 (de) |
BR (1) | BRPI0815758B1 (de) |
CA (1) | CA2696865C (de) |
DK (2) | DK3034097T3 (de) |
ES (2) | ES2671026T3 (de) |
IL (1) | IL203573A (de) |
MX (1) | MX2010001919A (de) |
RU (1) | RU2491292C2 (de) |
TR (1) | TR201807044T4 (de) |
WO (1) | WO2009024620A2 (de) |
ZA (1) | ZA201001246B (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008008872A2 (en) | 2006-07-14 | 2008-01-17 | Wisconsin Alumni Research Foundation | Adsorptive membranes for trapping viruses |
KR101576219B1 (ko) | 2007-03-14 | 2015-12-10 | 다케다 백신즈 인코포레이티드 | 바이러스 유사 입자 정제 |
EP2027875A1 (de) * | 2007-08-23 | 2009-02-25 | Octapharma AG | Verfahren zur Isolierung und Reinigung eines prionenproteinfreien Target-Proteins |
ES2610529T3 (es) * | 2010-03-30 | 2017-04-28 | Octapharma Ag | Un procedimiento de purificación de proteínas dependientes de vitamina K, tales como el factor de coagulación IX |
WO2011121031A1 (en) | 2010-03-30 | 2011-10-06 | Octapharma Ag | Process for the purification of a growth factor protein |
RU2591523C2 (ru) * | 2010-11-05 | 2016-07-20 | Ф. Хоффманн-Ля Рош Аг | Оптимизированный метод захвата антител хроматографией смешанного типа |
SG191186A1 (en) | 2010-12-15 | 2013-07-31 | Baxter Int | Eluate collection using conductivity gradient |
US20120183527A1 (en) * | 2011-01-18 | 2012-07-19 | Baxter International Inc. | Measurement of anti-amyloid antibodies in human blood |
AU2012213432B2 (en) * | 2011-02-01 | 2016-10-13 | Novo Nordisk A/S | Purification of insulin |
CN102675414A (zh) * | 2011-03-08 | 2012-09-19 | 上海天伟生物制药有限公司 | 糖蛋白中去除/灭活朊病毒的方法 |
JP6151640B2 (ja) * | 2011-06-29 | 2017-06-21 | 協和発酵キリン株式会社 | たん白質の精製方法 |
JOP20130186B1 (ar) | 2012-06-22 | 2021-08-17 | Takeda Vaccines Montana Inc | تنقية الجزيئات الشبيهة بالفيروسات |
KR102125695B1 (ko) * | 2012-10-03 | 2020-06-24 | 체에스엘 베링 아게 | 단백질 정제 방법 |
US20140154233A1 (en) * | 2012-12-05 | 2014-06-05 | Csl Limited | Method of purifying therapeutic proteins |
US10188965B2 (en) | 2012-12-05 | 2019-01-29 | Csl Behring Gmbh | Hydrophobic charge induction chromatographic depletion of a protein from a solution |
CN103336124B (zh) * | 2012-12-11 | 2015-07-15 | 武汉工业学院 | 一种检测朊病毒蛋白(PrPSC)的方法和试剂盒 |
EP3160611A4 (de) * | 2014-06-25 | 2018-02-28 | JHL Biotech, Inc. | Verfahren und reagenzien zur reinigung von proteinen |
WO2016207328A1 (en) * | 2015-06-24 | 2016-12-29 | Glycotope Gmbh | PROCESS FOR THE PURIFICATION OF γ-CARBOXYLATED POLYPEPTIDES |
DE102016004432A1 (de) * | 2016-04-12 | 2017-10-12 | Sartorius Stedim Biotech Gmbh | Multimodales Adsorptionsmedium mit multimodalen Liganden, Verfahren zu dessen Herstellung und dessen Verwendung |
CN110314414B (zh) * | 2019-07-23 | 2021-10-19 | 宝锐生物科技泰州有限公司 | 凝血因子xiii的分离纯化方法及其应用 |
CN112409476B (zh) * | 2020-08-13 | 2022-03-29 | 中元汇吉生物技术股份有限公司 | 四种血液来源蛋白的纯化方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5234991A (en) | 1975-07-29 | 1993-08-10 | Pasteur Merieux Serums And Vaccines | Porous mineral support coated with an aminated polysaccharide polymer |
FR2616437B1 (fr) | 1987-06-11 | 1990-09-07 | Ibf | Polymeres composites, leur preparation et leur utilisation en chromatographie liquide |
US5268097A (en) | 1992-06-19 | 1993-12-07 | Sepracor Inc. | Passivated and stabilized porous mineral oxide supports and method for the preparation and use of same |
US5316680A (en) * | 1992-10-21 | 1994-05-31 | Cornell Research Foundation, Inc. | Multimodal chromatographic separation media and process for using same |
AT405119B (de) | 1996-06-28 | 1999-05-25 | Poschik Roland | Vorrichtung zur betätigung des schiebers eines reissverschlusses, sowie reissverschluss |
US5808011A (en) * | 1996-07-01 | 1998-09-15 | Biopure Corporation | Method for chromatographic removal of prions |
WO2000043048A1 (en) * | 1999-01-19 | 2000-07-27 | Common Services Agency | Treating protein-containing liquids |
GB0214007D0 (en) * | 2002-06-18 | 2002-07-31 | Common Services Agency | Removal of prion infectivity |
JP2005539223A (ja) * | 2002-09-13 | 2005-12-22 | ポール コーポレイション | クロマトグラフィーの吸着剤およびバイオチップアレイのための混合モード固体基材の調製および使用 |
US7750129B2 (en) * | 2004-02-27 | 2010-07-06 | Ge Healthcare Bio-Sciences Ab | Process for the purification of antibodies |
SE0400501D0 (sv) | 2004-02-27 | 2004-02-27 | Amersham Biosciences Ab | Antibody purification |
EP1707634A1 (de) * | 2005-03-29 | 2006-10-04 | Octapharma AG | Verfahren zur Isolierung von rekombinant hergestellten Proteinen |
EP2027875A1 (de) * | 2007-08-23 | 2009-02-25 | Octapharma AG | Verfahren zur Isolierung und Reinigung eines prionenproteinfreien Target-Proteins |
US8329871B2 (en) * | 2008-06-24 | 2012-12-11 | Octapharma Ag | Process of purifying coagulation factor VIII |
WO2011121031A1 (en) * | 2010-03-30 | 2011-10-06 | Octapharma Ag | Process for the purification of a growth factor protein |
-
2007
- 2007-08-23 EP EP07114856A patent/EP2027875A1/de not_active Ceased
-
2008
- 2008-08-25 RU RU2010110805/10A patent/RU2491292C2/ru active
- 2008-08-25 TR TR2018/07044T patent/TR201807044T4/tr unknown
- 2008-08-25 WO PCT/EP2008/061068 patent/WO2009024620A2/en active Application Filing
- 2008-08-25 DK DK15198333.5T patent/DK3034097T3/en active
- 2008-08-25 BR BRPI0815758-8A patent/BRPI0815758B1/pt active IP Right Grant
- 2008-08-25 KR KR1020107003554A patent/KR20100057614A/ko not_active Application Discontinuation
- 2008-08-25 JP JP2010521447A patent/JP5797404B2/ja active Active
- 2008-08-25 MX MX2010001919A patent/MX2010001919A/es unknown
- 2008-08-25 DK DK08787446.7T patent/DK2190486T3/en active
- 2008-08-25 ES ES15198333.5T patent/ES2671026T3/es active Active
- 2008-08-25 CN CN200880104009XA patent/CN101842121B/zh active Active
- 2008-08-25 EP EP15198333.5A patent/EP3034097B1/de active Active
- 2008-08-25 ES ES08787446T patent/ES2572352T3/es active Active
- 2008-08-25 US US12/733,306 patent/US9296799B2/en active Active
- 2008-08-25 AU AU2008290482A patent/AU2008290482B2/en active Active
- 2008-08-25 CA CA2696865A patent/CA2696865C/en active Active
- 2008-08-25 EP EP08787446.7A patent/EP2190486B1/de active Active
-
2010
- 2010-01-28 IL IL203573A patent/IL203573A/en active IP Right Grant
- 2010-02-22 ZA ZA201001246A patent/ZA201001246B/xx unknown
-
2015
- 2015-12-29 US US14/982,148 patent/US20160152661A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2008290482B2 (en) | 2013-10-03 |
BRPI0815758B1 (pt) | 2018-08-07 |
EP2027875A1 (de) | 2009-02-25 |
EP2190486A2 (de) | 2010-06-02 |
IL203573A (en) | 2013-11-28 |
JP5797404B2 (ja) | 2015-10-21 |
CA2696865C (en) | 2019-09-17 |
RU2010110805A (ru) | 2011-09-27 |
ES2572352T3 (es) | 2016-05-31 |
MX2010001919A (es) | 2010-03-15 |
JP2010536832A (ja) | 2010-12-02 |
US20100210821A1 (en) | 2010-08-19 |
EP2190486B1 (de) | 2016-03-23 |
TR201807044T4 (tr) | 2018-06-21 |
CN101842121B (zh) | 2013-10-30 |
CN101842121A (zh) | 2010-09-22 |
DK2190486T3 (en) | 2016-07-04 |
AU2008290482A1 (en) | 2009-02-26 |
CA2696865A1 (en) | 2009-02-26 |
WO2009024620A2 (en) | 2009-02-26 |
ES2671026T3 (es) | 2018-06-04 |
WO2009024620A3 (en) | 2009-04-23 |
RU2491292C2 (ru) | 2013-08-27 |
DK3034097T3 (en) | 2018-06-06 |
KR20100057614A (ko) | 2010-05-31 |
EP3034097A1 (de) | 2016-06-22 |
EP3034097B1 (de) | 2018-02-28 |
US9296799B2 (en) | 2016-03-29 |
BRPI0815758A2 (pt) | 2014-10-21 |
US20160152661A1 (en) | 2016-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201001246B (en) | A process for isolation and purification of a target protein free of prion protein (PRPSC) | |
IL199753A0 (en) | Process for the purification of fc-containing proteins | |
HK1131400A1 (en) | Process for the purification of fc-containing proteins | |
IL214832A0 (en) | 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication | |
IL219755A0 (en) | Modified ubiquitin proteins having a specific binding activity for the extradomain b of fibronectin | |
EP2291388A4 (de) | Verfahren zur aufreinigung von antikörpern | |
IL225650A0 (en) | Protein purification processes | |
ZA200900836B (en) | Process for the purification of FC-fusion proteins | |
IL197765A0 (en) | Methods for purification of polypeptide conjugates | |
IL214434A (en) | A method for separating an antibody or protein containing an antibody fragment from one or more contaminants | |
HK1148684A1 (en) | Treatment of prion protein related diseases | |
IL215562A0 (en) | Process for isolating therapeutic peptide | |
ZA200900837B (en) | Process for the purification of FC-containing proteins | |
ZA200900626B (en) | 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication | |
EP1995322A4 (de) | Verfahren zur reinigung von aminosäure | |
GB2439562C2 (en) | System for analysis of electrograms | |
PT2427482T (pt) | Método para purificação de polipéptidos alvo | |
EP2045324A4 (de) | Verfahren zur herstellung n36-bindender peptide | |
EP2214674A4 (de) | Inhibitoren von anti-apoptotischen proteinen | |
IL200448A0 (en) | Processes for purification of tigecycline | |
GB0709037D0 (en) | Isolation of proteins | |
AU2007904281A0 (en) | Treatment of prion protein related diseases | |
EP2473169A4 (de) | Verfahren zur isolation und reinigung von enfumafungin | |
GB0615881D0 (en) | Novel peptide for treatment of asthma | |
EP2199284A4 (de) | Pharmazeutische zusammensetzung zur inhibierung der akkumulation von amyloid-beta-protein |